Table 2.
Differences of SARS-COV, MERS CoV, SARS-COV-2.
SARS-CoV | MERS-CoV | SARS-CoV-2 | |
---|---|---|---|
First notified | November 2002 in China’s Guangdong province | September 2012, in Saudi Arabia | December 2019 in Wuhan, China |
Mode of transmission | Infected civets, droplets produced by sneezing, coughing, breathing, talking | Droplets from person to person (unclear from camels to humans) | Droplets by coughing, sneezing, talking |
Mean incubation period | 4−5 days | 6−7 days | 1−14 days |
Key symptoms | Dry cough at first, fever, malaise, body aches and pains, diarrhea (in the first or second week) | Fever, cough, shortness of breath, nausea/vomiting, diarrhea | Fever, dry cough, shortness of breath, fatigue |
Treatment | No specific treatment | No specific treatment | No specific treatment |
Mortality rate | 11% | 34% | 3−4% |
Vaccine | No vaccine | No vaccine | No vaccine |